Cargando…

Liraglutide improves liver microvascular dysfunction in cirrhosis: Evidence from translational studies

Hepatic stellate cells (HSC) play a key role in the development of chronic liver disease (CLD). Liraglutide, well-established in type 2 diabetes, showed anti-inflammatory and anti-oxidant properties. We evaluated the effects of liraglutide on HSC phenotype and hepatic microvascular function using di...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Mesquita, Fernanda Cristina, Guixé-Muntet, Sergi, Fernández-Iglesias, Anabel, Maeso-Díaz, Raquel, Vila, Sergi, Hide, Diana, Ortega-Ribera, Martí, Rosa, José Luís, García-Pagán, Juan Carlos, Bosch, Jaime, de Oliveira, Jarbas Rodrigues, Gracia-Sancho, Jordi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468330/ https://www.ncbi.nlm.nih.gov/pubmed/28607430 http://dx.doi.org/10.1038/s41598-017-02866-y

Ejemplares similares

4 in 1: Antibody‐free protocol for isolating the main hepatic cells from healthy and cirrhotic single rat livers
por: Fernández‐Iglesias, Anabel, et al.
Publicado: (2018)

Emricasan Ameliorates Portal Hypertension and Liver Fibrosis in Cirrhotic Rats Through a Hepatocyte‐Mediated Paracrine Mechanism
por: Gracia‐Sancho, Jordi, et al.
Publicado: (2019)

Advances in therapeutic options for portal hypertension
por: Vilaseca, Marina, et al.
Publicado: (2018)

Nuclear deformation mediates liver cell mechanosensing in cirrhosis
por: Guixé-Muntet, Sergi, et al.
Publicado: (2020)

Mechanobiology of portal hypertension
por: Felli, Eric, et al.
Publicado: (2023)

The Hepatic Sinusoid in Chronic Liver Disease: The Optimal Milieu for Cancer
por: Gibert-Ramos, Albert, et al.
Publicado: (2021)

Regression of portal hypertension: underlying mechanisms and therapeutic strategies
por: Selicean, Sonia, et al.
Publicado: (2021)

Effects of aging on liver microcirculatory function and sinusoidal phenotype
por: Maeso‐Díaz, Raquel, et al.
Publicado: (2018)

Effects of warm ischemia and reperfusion on the liver microcirculatory phenotype of rats: underlying mechanisms and pharmacological therapy
por: Hide, Diana, et al.
Publicado: (2016)

Aging Influences Hepatic Microvascular Biology and Liver Fibrosis in Advanced Chronic Liver Disease
por: Maeso-Díaz, Raquel, et al.
Publicado: (2019)

Review article: vascular effects of PPARs in the context of NASH
por: Guixé‐Muntet, Sergi, et al.
Publicado: (2022)

Resemblance of the human liver sinusoid in a fluidic device with biomedical and pharmaceutical applications
por: Ortega‐Ribera, Martí, et al.
Publicado: (2018)

New Rat Model of Advanced NASH Mimicking Pathophysiological Features and Transcriptomic Signature of The Human Disease
por: Maeso-Díaz, Raquel, et al.
Publicado: (2019)

Transcriptomic Profiling of the Liver Sinusoidal Endothelium during Cirrhosis Reveals Stage-Specific Secretory Signature
por: Manicardi, Nicolò, et al.
Publicado: (2021)

A Nutraceutical Rich in Docosahexaenoic Acid Improves Portal Hypertension in a Preclinical Model of Advanced Chronic Liver Disease
por: Boyer-Diaz, Zoe, et al.
Publicado: (2019)

How to Face Chronic Liver Disease: The Sinusoidal Perspective
por: Fernández-Iglesias, Anabel, et al.
Publicado: (2017)

The Hepatic Sinusoid in Aging and Disease: Update and Advances From the 20th Liver Sinusoid Meeting
por: Ortega‐Ribera, Martí, et al.
Publicado: (2020)

A Novel Modular Bioreactor to In Vitro Study the Hepatic Sinusoid
por: Illa, Xavi, et al.
Publicado: (2014)

Exercise Attenuates the Transition from Fatty Liver to Steatohepatitis and Reduces Tumor Formation in Mice
por: Guarino, Maria, et al.
Publicado: (2020)

Treatment of an Adolescent Female With Nonalcoholic Steatohepatitis–Related Cirrhosis With Liraglutide
por: Yuen, Christina, et al.
Publicado: (2023)

Cell Death in Hepatocellular Carcinoma: Pathogenesis and Therapeutic Opportunities
por: García-Pras, Ester, et al.
Publicado: (2021)

New Insights into the Use of Liraglutide—Impact on Cardiovascular Risk and Microvascular Outcomes
por: Wronka, Magdalena, et al.
Publicado: (2023)

Increased sinusoidal pressure impairs liver endothelial mechanosensing, uncovering novel biomarkers of portal hypertension
por: Ortega-Ribera, Martí, et al.
Publicado: (2023)

In Vitro Models for the Study of Liver Biology and Diseases: Advances and Limitations
por: Kaur, Savneet, et al.
Publicado: (2022)

Liraglutide and Glycaemic Outcomes in the LEADER Trial
por: Zinman, Bernard, et al.
Publicado: (2018)

Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis
por: Garcia Garcia de Paredes, Ana, et al.
Publicado: (2021)

Locally delivered GLP-1 analogues liraglutide and exenatide enhance microvascular perfusion in individuals with and without type 2 diabetes
por: Aung, Myo Myo, et al.
Publicado: (2019)

Effect of Meal Ingestion on Liver Stiffness in Patients with Cirrhosis and Portal Hypertension
por: Berzigotti, Annalisa, et al.
Publicado: (2013)

Mechanism of action of and resistance to quinolones
por: Fàbrega, Anna, et al.
Publicado: (2009)

Spontaneous portosystemic shunts in liver cirrhosis: new approaches to an old problem
por: Vidal-González, Judit, et al.
Publicado: (2020)

Molecular Profiling of Decompensated Cirrhosis by a Novel MicroRNA Signature
por: Garcia Garcia de Paredes, Ana, et al.
Publicado: (2020)

Liraglutide – Indian Experience
por: Anirban, Majumder, et al.
Publicado: (2018)

Liraglutide-Induced Hepatotoxicity
por: Maor, Yaakov, et al.
Publicado: (2021)

Interaction between NO and COX pathways modulating hepatic endothelial cells from control and cirrhotic rats
por: Rosado, Eugenio, et al.
Publicado: (2012)

Endothelial and microvascular function in liver cirrhosis: an old concept that needs re-evaluation?
por: Papagiouvanni, Ioanna, et al.
Publicado: (2022)

Emerging Therapeutic Targets for Portal Hypertension
por: Felli, Eric, et al.
Publicado: (2023)

Liraglutide restores impaired associative learning in individuals with obesity
por: Hanssen, Ruth, et al.
Publicado: (2023)

Working with laboratory rodents in Spain: a survey on welfare and wellbeing
por: Goñi-Balentziaga, Olatz, et al.
Publicado: (2021)

A survey on the use of mice, pigs, dogs and monkeys as animal models in biomedical research in Spain
por: Goñi-Balentziaga, Olatz, et al.
Publicado: (2022)

Continuation of Liraglutide during Fasting is not Associated with Hypoglycaemia
por: Koot, Rosalie, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ofmksjti3p02u4povctotquqq9